Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
RGNX vs XNCR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
XNCR Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)
XNCR Overall Winner
6-Pillar Tally: RGNX 2 – 4 XNCR
Matrix Metrics: RGNX 2 – 8 XNCR
As of Nov 16, 2026, Xencor, Inc. (XNCR) is the stronger overall head-to-head candidate over REGENXBIO Inc. (RGNX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RGNX carries a Unified Composite Score of 45.3/100 (HOLD) at $7.47 (N/M Forward P/E, -120.4% operating margin), whereas XNCR carries 29.6/100 (SELL) at $35.62 (68.0x Forward P/E, -72.7% operating margin).
- Composite vs. Pillar Nuance: While RGNX currently prints a higher short-term Unified Composite Score (45.3/100 HOLD vs. XNCR 29.6/100 SELL), XNCR captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-72.7% vs. -120.4% operating margin) and revenue trajectory (+454.9% vs. -69.2% YoY).
- Technical & Structure Timing Caution: RGNX is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 48.3); meanwhile XNCR trades in a Markup technical trend (BREAKOUT options phase, RSI 62.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About RGNX vs XNCR
RGNX
REGENXBIO Inc.
$7.47
-2.23% 1D
Market Cap
$500.9M
TTM Revenue
$154M
Forward P/E
N/M
Beta / 30D Vol
1.81β · 76% Vol
Unified Composite Score
45.3
HOLD
Tech 36.0
Fund 44.0
Flow 69.0
Mom 50.0
Weinstein Technical Phase
Distribution · Trim / tighten stop
XNCR
Head-to-Head Winner
Xencor, Inc.
$35.62
-3.98% 1D
Market Cap
$2.9B
TTM Revenue
$200M
Forward P/E
68.0x
Beta / 30D Vol
1.19β · 86% Vol
Unified Composite Score
29.6
SELL
Tech 50.0
Fund 32.0
Flow 66.0
Mom 40.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (RGNX 2 – 4 XNCR)
1. Valuation Multiples
XNCR
Forward P/E
N/M
68.0x
Trailing P/E
N/M
68.0x
PEG Ratio
0.26x
N/M
EV / Revenue
3.1x
14.8x
2. Growth & Scale
XNCR
Revenue Growth (YoY)
-69.2%
+454.9%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$154M
$200M
Market Cap
$500.9M
$2.9B
3. Profitability & Quality
XNCR
Gross Margin
-64.5%
-42.5%
Operating Margin
-120.4%
-72.7%
Net Profit Margin
-113.9%
-58.8%
Return on Equity (ROE)
-113.2%
-19.9%
4. Balance Sheet & Cash Flow
RGNX
Cash Generation (TTM)
-$155M
-$176M
Cash Flow Margin
-100.6%
-88.0%
Net Cash / Leverage
$29M Net Cash
$101M Net Debt (0.29x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
XNCR
Options Structure Phase
BREAKDOWN
BREAKOUT
Current IV / %ile
349.6% (52nd %ile)
79.0% (10th %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
ACCUMULATION · Distribution
ACCUMULATION · Markup
6. R&D & Supply-Chain Moat
RGNX
OpEx & R&D Intensity
55.9% of Rev ($86M)
30.2% of Rev ($61M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Biotechnology Operator
Biotechnology Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: RGNX (2) vs XNCR (8)| Institutional Metric | RGNX | XNCR | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $500.9M | $2.9B | XNCR | |
| Trailing P/E Ratio | N/M | 68.0x | XNCR | |
| Forward P/E Ratio | N/M | 68.0x | XNCR | |
| Revenue Growth (YoY) | -69.2% | +454.9% | XNCR | |
| Operating Margin (TTM) | -120.4% | -72.7% | XNCR | |
| Net Profit Margin | -113.9% | -58.8% | XNCR | |
| Return on Equity (ROE) | -113.2% | -19.9% | XNCR | |
| 52-Week Range Position | 19% ($5–$16) | 84% ($10–$41) | XNCR | |
| Beta / 30D Volatility | 1.81β · 76% Vol | 1.19β · 86% Vol | RGNX | |
| Unified Institutional Score | 45.3 / 100 (HOLD) | 29.6 / 100 (SELL) | RGNX | |
| Trailing 12M Revenue (USD) | $154M | $200M | Scale | |
| Gross Profit Margin (TTM) | -64.5% | -42.5% | Quality | |
| PEG Ratio & EV / Revenue | 0.26x PEG · 3.1x EV/Rev | N/M PEG · 14.8x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$155M ($29M Net Cash) | -$176M ($101M Net Debt (0.29x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
XNCR +47.99 pp
3M Horizon
XNCR +72.68 pp
6M Horizon
XNCR +189.81 pp
1Y Horizon
XNCR +190.39 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | RGNX Revenue | XNCR Revenue | RGNX Op. Margin | XNCR Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $220M | $40M | 40.3% | -195.5% | RGNX |
| FY2019 | $40M | $160M | -422.9% | 8.8% | XNCR |
| FY2020 | $150M | $120M | -77.1% | -62.6% | XNCR |
| FY2021 | $470M | $280M | 34.0% | 15.9% | RGNX |
| FY2022 | $110M | $160M | -233.2% | -50.1% | XNCR |
| FY2023 | $90M | $170M | -297.1% | -75.8% | XNCR |
| FY2024 | $80M | $110M | -280.0% | -161.5% | XNCR |
| FY2025 | $170M | $130M | -94.6% | -141.4% | RGNX |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
RGNX
BREAKDOWN
Current IV
349.6%
IV Percentile
52nd %ile
Put/Call OI Skew
N/A
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact RGNX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
XNCR
BREAKOUT
Current IV
79.0%
IV Percentile
10th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
ACCUMULATION
Exact XNCR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
RGNX Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
55.9% of Rev ($86M)
90D Engineering Disclosures
0 Published
XNCR Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
30.2% of Rev ($61M)
90D Engineering Disclosures
0 Published
Investor FAQ RGNX vs XNCR Key Questions & Quantitative Answers
As of Nov 16, 2026, Xencor, Inc. (XNCR) is the stronger overall head-to-head candidate over REGENXBIO Inc. (RGNX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RGNX carries a Unified Composite Score of 45.3/100 (HOLD) at $7.47 (N/M Forward P/E, -120.4% operating margin), whereas XNCR carries 29.6/100 (SELL) at $35.62 (68.0x Forward P/E, -72.7% operating margin). Composite vs. Pillar Nuance: While RGNX currently prints a higher short-term Unified Composite Score (45.3/100 HOLD vs. XNCR 29.6/100 SELL), XNCR captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-72.7% vs. -120.4% operating margin) and revenue trajectory (+454.9% vs. -69.2% YoY). Technical & Structure Timing Caution: RGNX is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 48.3); meanwhile XNCR trades in a Markup technical trend (BREAKOUT options phase, RSI 62.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
XNCR leads the Growth & Scale pillar: RGNX posts -69.2% YoY revenue growth and +0.0% YoY earnings growth on $154M TTM revenue (-64.5% gross margin, -120.4% operating margin), compared with XNCR at +454.9% YoY revenue growth and +0.0% YoY earnings growth on $200M TTM revenue (-42.5% gross margin, -72.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), RGNX cumulative revenue shifted -22.7% while XNCR shifted +225.0%. In operating R&D and SG&A reinvestment, RGNX deploys 55.9% of Rev ($86M) (0 90-day corporate R&D disclosures) versus 30.2% of Rev ($61M) (0 disclosures) for XNCR.
XNCR screens cheaper on headline valuation multiples. RGNX trades at N/M Forward P/E, N/M Trailing P/E, 0.26x PEG, and 3.1x EV/Revenue (-100.6% FCF margin), whereas XNCR trades at 68.0x Forward P/E, 68.0x Trailing P/E, N/M PEG, and 14.8x EV/Revenue (-88.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RGNX (-113.2% ROE) versus XNCR (-19.9% ROE) capital efficiency.
In options market volatility and institutional positioning, RGNX carries 349.6% implied volatility (52nd %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.81β · 76% Vol realized risk). By comparison, XNCR carries 79.0% implied volatility (10th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (1.19β · 86% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
XNCR vs RGNX · Reverse Pair
RGNX vs QURE
· Sector Peer
RGNX vs MGTX
· Sector Peer
RGNX vs RARE
· Sector Peer
XNCR vs ENTA
· Sector Peer
XNCR vs ANAB
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem